# A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan

> **NCT06741683** · PHASE2,PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 187 (actual)

## Conditions studied

- Dengue Fever

## Interventions

- **BIOLOGICAL:** TDV
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06741683
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-31
- **Primary completion:** 2025-07-09
- **Final completion:** 2025-12-17
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741683, "A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06741683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*